CHARLES VINCENT KURKUL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology DENTON, TX NPI 1134419682
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$6,675.50
- Category: General Payments
- Program years: PY2018–2024
- Record count: 100
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,692.89 across 32 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $1,163.66 | 12 |
| Food and Beverage | $529.23 | 20 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,177.88 | 13 |
| Sirtex Medical Inc | $105.34 | 1 |
| Tempus AI, Inc | $74.14 | 3 |
| INTUITIVE SURGICAL, INC. | $37.48 | 1 |
| PharmaEssentia USA Corporation | $34.44 | 1 |
| Acerta Pharma LLC | $34.05 | 2 |
| Dendreon Pharmaceuticals LLC | $33.06 | 1 |
| Celgene Corporation | $32.98 | 2 |
| Janssen Biotech, Inc. | $27.64 | 1 |
| Astellas Pharma US Inc | $25.80 | 1 |
| Merck Sharp & Dohme Corporation | $24.64 | 1 |
| Lilly USA, LLC | $22.13 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.00 | 1 |
| ARRAY BIOPHARMA INC | $15.59 | 1 |
| Incyte Corporation | $14.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.83 | 1 |
By program year
Records — PY2024 (32)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.